News
& Events
What´s new at Flavine? We´ll keep you updated on any development and news on this page. Feel free to share also our event informations!
New Flavine Proprietary API
Flavine is embarking upon a new pipeline of proprietary master files of generic APIs for all markets. We are proud to announce the availability of Ruxolitinib Phosphate API.
Flavine has partnered with a reputed CDMO to develop and manufacture Ruxolitinib Phosphate. Flavine can support your filing strategy by utilizing our expertise of serving the generic industry for 45+ years.
Ruxolitinib Phosphate is a potent and selective anticancer, inhibitor of Janus kinase‑1 and Janus kinase‑2. As a BCS Class I drug, it is a candidate for BCS bio-waiver in lieu of BE study.
Ruxolitinib Phosphate is indicated for these therapeutic treatments:
- Intermediate or high-risk myelofibrosis (MF)
- Resistant forms of polycythemia vera (PV)
- Acute and chronic graft-vs-host disease (GVHD)
- Topical treatment of atopic dermatitis
- Topical treatment of nonsegmental vitiligo
Contact Flavine for Ruxolitinib Phosphate samples and more information on other salts.
Disclaimer: All products which are covered under current patents are available only for use reasonably related to the development and submission of information to the related Health Authorities to the extent permitted under applicable laws regulating the manufacture, use and sales of Active Pharmaceutical Ingredients and/or their intermediates.
New Development — Ruxolitinib Phosphate API
Approved Ruxolitinib Phosphate finished dosage forms:
- JAKAFI® (oral tablets) by Incyte Corporation
- OPZELURA™ (topical cream) by Incyte Corporation
- JAKAVI® (oral tablets) licensed to Novartis
New Laboratory Facility
New EU Retest & Release Laboratory
In a world where the healthcare revolution is increasingly transforming our lives, Flavine is leading the expansion of sourcing activities for its customers. For more than 45 years, we are thriving to add value to the business of both suppliers and customers by locating and developing quality manufacturers and opening up new markets.
Flavine is excited to announce our new, state of the art, GMP-compliant laboratory facility that offers comprehensive analytical services, QC retest, and release testing of active pharmaceutical ingredients and finished dosage forms. Complementing our full-service QC testing, we also provide robust method development, validation, and transfer of pharmaceutical products and raw materials.
New GMP Sampling Installation:
- Changing room
- Sampling area with laminar air flow and HEPA filtration
- Suitable scales for various package shipment sizes
- Interlocking doors system
- Separate operations for the flow of material and personnel
- Routine environmental monitoring
- Control and monitoring of microbiological quality
- Airlocks and pass-throughs chamber
Next Events
Veterinary Meeting & Expo
25 January 2025 – 29 January 2025, Orlando, Florida, USA, VMX…
Read MoreWestern Veterinary Conference
02 March 2025 – 05 March 2025, Mandalay Bay Convention…
Read MoreCPhI North America
May 20, 2025 – May 22, 2025, Pennsylvania Convention Center, Philadelphia,…
Read MoreCPhI China
Start date: 24 Jun 2025 End date: 26 Jun 2025 Shanghai…
Read MoreCPhI Worldwide
28 October 2025 — 30 October 2025, CPHI Frankfurt 2025 Messe Frankfurt…
Read MoreAPI China 2025
Dates: TBD, Xi’an International Convention & Exhibition Center, Xian, China https://www.eventseye.com/fairs/f‑api-china-12694–1.html
Read MoreCPHI India
Start date November 25th, 2025 End date November 27th, 2025 CPHI…
Read More